"The University of Missouri opened a medical school in Kansas City in 1971 to meet the health care needs of Missouri and the nation. Using an alternative approach to medical education from that of the traditional four-year school, the UMKC School of Medicine accepts students directly out of high school for the combined baccalaureate/ Doctor of Medicine program, which allows students to graduate in six years with their medical degree."

During the past decade, Univ of Missouri at Kansas City School of Medicine conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 7 clinical trials were completed, i.e. on average, 233.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Univ of Missouri at Kansas City School of Medicine" #1 sponsor was "Glaxo Wellcome" with 4 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "American Lung Association Asthma Clinical Research Centers" with 2 trials sponsored, "Johns Hopkins University" with 2 trials sponsored and "Pharmacia and Upjohn" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Univ of Missouri at Kansas City School of Medicine" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "American Lung Association" with 1 trials as a collaborator, "American Lung Association Asthma Clinical Research Centers" with 1 trials as a collaborator and "Geisinger Clinic" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Univ of Missouri at Kansas City School of Medicine" are "HIV Infections" (13 trials), "Asthma" (5 trials), "Diarrhea" (2 trials), "Histoplasmosis" (2 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Univ of Missouri at Kansas City School of Medicine" in a lesser frequency.

Most popular intervention types in "Univ of Missouri at Kansas City School of Medicine" are "Drug" (21 trials), "Biological" (3 trials), "Device" (3 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (4 trials), "Delavirdine mesylate" (3 trials), "Lamivudine" (3 trials), "Fluconazole" (2 trials) and "Itraconazole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Univ of Missouri at Kansas City School of Medicine" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Univ of Missouri at Kansas City School of Medicine". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Univ of Missouri at Kansas City School of Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Univ of Missouri at Kansas City School of Medicine, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 13 trials that are defined as “Not Applicable".